Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
APRE
LGVN
Add up to 3 more stocks
APRE
Aprea Therapeutics, Inc.
-2.74%
$0.66-0.02Delayed quote: Oct 6, 2026, 11:30 AM EDT
Market Cap
$8.14M
52W Range
$0.55 - $1.69
LGVN
Longeveron Inc.
-2.79%
$2.44-0.07Delayed quote: Oct 6, 2026, 11:24 AM EDT
Market Cap
$7.43M
52W Range
$2.30 - $12.30
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.21 | 0.71 |
| P/S Ratio | N/A | 6.26 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 69.8% |
| Operating Margin | 0.0% | -1942.2% |
| Net Margin | 0.0% | -1977.6% |
| ROE | -32.0% | -225.7% |
| ROA | -29.1% | -151.6% |
| ROIC | -33.7% | -211.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 13.55 | 2.63 |
| Quick Ratio | 13.55 | 2.63 |
| Debt/Equity | 0.00 | 0.06 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.